15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.

Clinical trial NCT00495729 · COMPLETED

Trial details

NCT number: NCT00495729
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sleep Initiation and Maintenance Disorders

Start date: 2007-04-18
Primary completion: 2007-08-04
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.